
Yerem Yeghiazarians founder and CEO of Soley Therapetuics touches on how Soley's approach reverses traditional drug development and reduces failure risks.
Professor of Medicine Past Leone-Perkins Family Endowed Chair in Cardiology San Francisco Board Past-President, American Heart Association Past Co-Director, Adult Cardiac Catheterization Laboratory Past Director, Peripheral Interventional Cardiology Program Past Director, Translational Cardiac Stem Cell Program Cardiovascular Research Institute Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Associate Member in Experimental Therapeutics, UCSF Helen Diller Cancer Center University of California, San Francisco